APA (7th ed.) Citation

Harnoß, J. M., Radhakrishnan, P., Leowardi-Bauer, C., Strowitzki, M., Schaible, A., Lasitschka, F., & Schneider, M. (2020). Prolyl hydroxylase inhibition Mitigates Pouchitis. Inflammatory bowel diseases, 26(2), . https://doi.org/10.1093/ibd/izz218

Chicago Style (17th ed.) Citation

Harnoß, Jonathan M., Praveen Radhakrishnan, Christine Leowardi-Bauer, Moritz Strowitzki, Anja Schaible, Felix Lasitschka, and Martin Schneider. "Prolyl Hydroxylase Inhibition Mitigates Pouchitis." Inflammatory Bowel Diseases 26, no. 2 (2020). https://doi.org/10.1093/ibd/izz218.

MLA (9th ed.) Citation

Harnoß, Jonathan M., et al. "Prolyl Hydroxylase Inhibition Mitigates Pouchitis." Inflammatory Bowel Diseases, vol. 26, no. 2, 2020, https://doi.org/10.1093/ibd/izz218.